BusinessInsurer will pay for pricey cholesterol drug — if it works By Robert Weisman — Boston GlobeNov. 9, 2015 Reprints Amgen Inc./AP A prominent Boston-area insurance plan will cover Amgen’s pricey new cholesterol drug — but will demand rebates if it doesn’t work. About the Author Reprints Robert Weisman — Boston Globe [email protected] @GlobeRobW Tags Amgen cholesterol insurance pharmaceuticals prescription drugs
Business Bob Herman STAT Plus: Wary of changes to Medicare Advantage, health insurers put up a fight — and exaggerate the stakes
Special Report Brittany Trang STAT Plus: As AI promises to revolutionize medical note-taking, concerns mount about accuracy and harm
Health Tech Mohana Ravindranath and Casey Ross STAT Plus: Cerebral and other telehealth startups face new legal and regulatory challenges over ad models
A STAT Investigation Casey Ross and Bob Herman STAT Plus: Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need
